EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Hemp-Derived Extracellular Vesicles: A Novel Frontier in Nanomedicine and Therapeutics

Hassan Azari, Hamid Moloudian, Nasser Koopaei, Renaud Sicard, Timothy M Ganey, Brent A Reynolds

BioDrugs · 2026-03 · 40 (2) · 197-214

DOI: 10.1007/s40259-026-00766-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioDrugs, online erschienen am 05.03.2026. Verfasst von Hassan Azari und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Health Professions and Medical Sciences, Barry University, Miami Shores, FL, USA. Hauptthemen laut MEDLINE: Cannabis, Nanomedicine, Extracellular Vesicles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 120 Literaturangaben. Gefördert von: Florida Department of Health, Consortium for Medical Marijuana Clinical Outcomes Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While mammalian-derived extracellular vesicles (EVs) face significant challenges in clinical translation due to scalability, cost, and safety, plant-derived EVs (PDEVs) have emerged as a promising alternative. This review focuses on EVs derived from hemp (Cannabis sativa L.), or HEVs, a particularly compelling source that combines the general benefits of PDEVs, such as improved safety and scalability, with a unique, inherent therapeutic cargo. HEVs are naturally enriched with a potent mix of cannabinoids, terpenes, and flavonoids, which may enhance therapeutic outcomes through synergistic interactions-a phenomenon known as the 'entourage effect.' Preclinical studies already demonstrate their potential, showing significant anti-cancer effects against aggressive tumors like glioblastoma, along with neuroprotective and anti-inflammatory properties. However, the critical challenge hindering their clinical application is the lack of standardized, GMP (Good Manufacturing Practice)-compliant manufacturing protocols to address the inherent biochemical variability of the source material. Overcoming these obstacles will be vital to unlocking the potential of HEVs as a novel, scalable frontier in nanomedicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabisNanomedicineExtracellular VesiclesHumansAnimalsCannabinoids

Substanzen

Cannabinoids

Autor:innen und Institutionen

  • College of Health Professions and Medical Sciences, Barry University, Miami Shores, FL, USA.
  • NanoScience Technology Center, University of Central Florida, Orlando, FL, USA.
  • Department of Chemistry, University of Central Florida, Orlando, FL, USA.
  • Erivan Bio, Gainesville, FL, USA.
  • VIVEX Biologics, Inc., Miami, FL, USA.
  • Department of Neurosurgery, University of Florida, Gainesville, FL, USA. bareynolds@ufl.edu.

Förderung

  • Florida Department of Health
  • Consortium for Medical Marijuana Clinical Outcomes Research

Zitieren

APA

Azari, H., Moloudian, H., Koopaei, N., Sicard, R., Ganey, T. M., & Reynolds, B. A. (2026). Hemp-Derived Extracellular Vesicles: A Novel Frontier in Nanomedicine and Therapeutics. BioDrugs, 40(2), 197-214. https://doi.org/10.1007/s40259-026-00766-0

Vancouver

Azari H, Moloudian H, Koopaei N, Sicard R, Ganey TM, Reynolds BA. Hemp-Derived Extracellular Vesicles: A Novel Frontier in Nanomedicine and Therapeutics. BioDrugs. 2026;40(2):197-214. doi:10.1007/s40259-026-00766-0

BibTeX
@article{Azari2026,
  author = {Azari, Hassan and Moloudian, Hamid and Koopaei, Nasser and Sicard, Renaud and Ganey, Timothy M and Reynolds, Brent A},
  title = {Hemp-Derived Extracellular Vesicles: A Novel Frontier in Nanomedicine and Therapeutics},
  journal = {BioDrugs},
  year = {2026},
  volume = {40},
  number = {2},
  pages = {197--214},
  doi = {10.1007/s40259-026-00766-0}
}
Kostenlos starten →